The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.

3 Ligand-Protein Interactions CHARACTERISTICS Molecular docking is used in structure-based drug design. The computational aspects can be divided into two parts.

Discover the best professional documents and content resources in AnyFlip Document Base.
Search
Published by , 2016-03-04 04:18:03

Dock 6: Beginners Tutorial - MSI

3 Ligand-Protein Interactions CHARACTERISTICS Molecular docking is used in structure-based drug design. The computational aspects can be divided into two parts.

Dock 6: Beginners Tutorial

Carlos P Sosa
Biomedical Informatics & Computational Biology,

University of Minnesota, Rochester
IBM, Minneapolis

Outline

Ligand-Proteins Interactions
Computers in Drug Discovery
How Does Dock6 Works?

2

Ligand-Protein Interactions

CHARACTERISTICS
Molecular docking is used in structure-based
drug design. The computational aspects can
be divided into two parts. Ligand atoms
being located inside the cavity or binding
pocket of a receptor, which is a large
biomolecule and scoring or identifying
the most favorable interactions

CHALLENGE
Improving code performance and scalability for virtual
screening of millions of ligands

USAGE
Drug Discovery
Compute-intensive applications

3

Computers in Drug Discovery

Image source: http://en.wikibooks.org/wiki/Proteomics/Proteomics_and_Drug_Discovery 4

Examples of Structure-Based
Virtual Screening Success Stories1

Drug Target Disease Target or Function Receptor SBVS Potency of Lead Scaffold
Method (IC50)
EGFR Cancer X-Ray ICM 10 µM
Casein Kinase 2 Prostate Cancer X-Ray 20 nM
MOE, Glide,
β-Secretase Alzheimers X-Ray FRED, and 10 µM
DPP-IV Diabetes X-Ray GOLD 3-70 µM
SARS-CoV SARS X-Ray SEED 23 µM
DHODH Cancer, arthritis, psoriasis, autoimmune X-Ray
DNA methyl-transferase Cancer Model FlexX
APE/REF-1 X-Ray
SHBG Melanoma X-Ray EUDOC
Endometrial cancer, ovarian dysfunction, male
SARS-CoV and female infertility and diabetes Model eHiTS
L-xylulose reductase SARS X-Ray
HSP90 Diabetes X-Ray DOCK
Phospho-triestase Cancer X-Ray
STAT3 Detoxification of organophosphates X-Ray ICM 13-124 µM
ER-β Cancer X-Ray GLIDE
Alzheimers
DOCK 4.01 Ki = 61-178 µM
DOCK 4.01 29-100 µM
RDOCK 0.6-26 µM
DOCK Kcat/Km = 106
DOCK4.0
GOLD 2.0 680 nM

1Cavasotto and Orry, Current Topics in Medicinal Chemistry, 2007, 7, 1006-1014

How Does DOCK Work?

1)
2)
3)

Add protons, Calculate
VDW parameters, solvent
accessible
and charges surface area

DOCK 5: Moustakas D and Lang PT, et al. J Comput Aided Mol Des (2006) Create negative image
20:601–619. of surface features
DOCK 6: Lang PT et al. (in preparation). using spheres

4)
Calculate energy grid
(each point contains
VDW score and charge
for that portion of
space)

5)

Match ligand to spheres
and score against grid

Preparing Molecules for Docking

Description of the steps required to prepare receptor and ligand molecules

http://dock.compbio.ucsf.edu/DOCK_6/tutorials/struct_prep/prepping_molecules.htm

Generating Spheres

Description of the steps required to prepare active site spheres

http://dock.compbio.ucsf.edu/DOCK_6/tutorials/sphere_generation/generating_spheres.htm

Generating the Grid

Description of the steps required to generate the grid used for grid-scoring

http://dock.compbio.ucsf.edu/DOCK_6/tutorials/grid_generation/generating_grid.html

Rigid and Flexible Ligand DOCKing

Description of the rigid and flexible-ligand docking to a rigid receptor
with grid-based scoring

http://dock.compbio.ucsf.edu/DOCK_6/tutorials/ligand_sampling_dock/ligand_sampling_
dock.html

Backup Slides

Massively Parallel Mode

Create database of potential drug candidates

For each independent node, load:
DOCK binary
Receptor input files
Subset of potential drug candidates

Store docking score results into database

Amanda Peters, Marcus E. Lundberg, Carlos P Sosa, and P. Therese Lang: “In Silico Virtual Screening on a Massively Parallel System “,
Midwest Symposium in Computational Biology and Bioinformatics, Northwestern University, Evanston, IL, October 2007.

Virtual Screening Process

Database Experiment

Molecular Docking Program In vitro

In silico

Thank You!

15


Click to View FlipBook Version